StockData
Telomir Pharmaceuticals, Inc. logo

Telomir Pharmaceuticals, Inc. (TELO) stock

TELONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$0.42−0.00 (-0.61%)

Close on Nov 18, 2026Market cap $28.92MP/E –Yield –

Telomir Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Telomir Pharmaceuticals

Telomir Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Telomir Pharmaceuticals figures

See a number that looks wrong?